Mandatory Child Protective Services Reporting for Substance-Exposed Newborns and Peripartum Outcomes: A Difference-in-Differences Analysis

Rohan Khazanchi; Elisha M Wachman; Davida M Schiff; Anna Modest; Kelley A Saia; Heather E Hsu

doi:10.1001/jamapediatrics.2024.0903

Mandatory Child Protective Services Reporting for Substance-Exposed Newborns and Peripartum Outcomes: A Difference-in-Differences Analysis

JAMA Pediatr. 2024 Jul 1;178(7):719-722. doi: 10.1001/jamapediatrics.2024.0903.

Authors

Rohan Khazanchi¹, Elisha M Wachman², Davida M Schiff³, Anna Modest⁴, Kelley A Saia⁵, Heather E Hsu²

Affiliations

¹ Harvard Internal Medicine-Pediatrics Residency Program at Brigham and Women's Hospital, Boston Children's Hospital, and Boston Medical Center, Boston, Massachusetts.
² Department of Pediatrics, Boston Medical Center, Boston, Massachusetts.
³ Department of Pediatrics, Massachusetts General Hospital, Boston.
⁴ Department of Obstetrics & Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
⁵ Department of Obstetrics & Gynecology, Boston Medical Center, Boston, Massachusetts.

PMID: 38709513
PMCID: PMC11074925 (available on 2025-05-06)
DOI: 10.1001/jamapediatrics.2024.0903

No abstract available

Plain language summary

This cross-sectional study examines data across 17 birthing hospitals before and after a policy change at Boston Medical Center in how reporting decisions are made in cases of prenatal substance exposure.

MeSH terms

Child Protective Services*
Female
Humans
Infant, Newborn
Male
Mandatory Reporting
Peripartum Period*
Pregnancy
Substance-Related Disorders / epidemiology

Grants and funding

K01 DA054328/DA/NIDA NIH HHS/United States